Daxor Corporation
About
Daxor Corporation (NASDAQ:DXR) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Apr 20 2026
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series
Apr 8 2026
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Mar 26 2026
Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
Mar 19 2026
Dynamic announces March 2026 cash distributions for Dynamic Active ETFs and ETF Series
Financials
Revenue
$26.69 K
Market Cap
$52.56 M
P/E Ratio
5.50
EPS
1.64